| 000 | 01585 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512195806.0 | ||
| 264 | 0 | _c19830119 | |
| 008 | 198301s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(82)90102-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, E A | |
| 245 | 0 | 0 |
_aEvidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cDec 1982 |
||
| 300 |
_a1237-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbumins _xadministration & dosage |
| 650 | 0 | 4 | _aBlood Volume |
| 650 | 0 | 4 |
_aBody Water _xmetabolism |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aCaptopril _xpharmacology |
| 650 | 0 | 4 |
_aEdema _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xmetabolism |
| 650 | 0 | 4 | _aPlasma Volume |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 700 | 1 | _aMarkandu, N D | |
| 700 | 1 | _aSagnella, G A | |
| 700 | 1 | _aSquires, M | |
| 700 | 1 | _aJones, B E | |
| 700 | 1 | _aMacGregor, G A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8310 _gp. 1237-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(82)90102-7 _zAvailable from publisher's website |
| 999 |
_c6128630 _d6128630 |
||